$141.97
2.64[1.89%]
At close: May 31
$141.97
0[0.00%]
After Hours: 4:34PM EDT
Quest Diagnostics
(NYSE:DGX)Quest Diagnostics Stock (NYSE:DGX), Insider Trading Activity
Quest Diagnostics: Insider buying and selling updated today.
Insider Shares Owned
2.085M
Insider Percentage Owned
1.88%
Institutional Shares Held
72.471M
Institutional Percentage Held
65.2%
| May 01, 2024 | Karthik Kuppusamy | SVP, CLINICAL SOLUTIONS | -1.76K | $140.00 | -$246.40K | SELL | -10.51% | 14.986K | Apr 29 | View |
| Mar 01, 2024 | Catherine T Doherty | EVP, REGIONAL BUSINESSES | -7.945K | $126.44 | -$1.00M | SELL | -9.84% | 72.761K | Feb 28 - Feb 29 | View |
| Mar 01, 2024 | Michael E Prevoznik | SVP & GENERAL COUNSEL | -6.472K | $125.94 | -$815.11K | SELL | -12.82% | 44.019K | Feb 28 - Feb 29 | View |
| Feb 23, 2024 | Michael E Prevoznik | SVP & GENERAL COUNSEL | -1.068K | $125.71 | -$134.26K | SELL | -2.28% | 45.747K | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | Vicky B Gregg | DIRECTOR | -2.5K | $126.64 | -$316.60K | SELL | -13.28% | 16.329K | Feb 23 | View |
| Feb 23, 2024 | Catherine T Doherty | EVP, REGIONAL BUSINESSES | -1.314K | $125.72 | -$165.20K | SELL | -1.72% | 75.149K | Feb 21 - Feb 22 | View |
| Mar 08, 2023 | Michael E Prevoznik | SVP & GENERAL COUNSEL | 0 | $145.84 | $34.75K | GRANT | 0.00% | 43.939K | Mar 06 - Mar 07 | View |
| Mar 08, 2023 | Catherine T Doherty | SVP, REGIONAL BUSINESSES | 0 | $145.90 | $38.79K | GRANT | 0.00% | 72.058K | Mar 06 - Mar 07 | View |
| Mar 06, 2023 | Catherine T Doherty | SVP, REGIONAL BUSINESSES | -717 | $140.63 | -$100.83K | SELL | -0.99% | 72.058K | Mar 03 | View |
| Mar 03, 2023 | Michael E Prevoznik | SVP & GENERAL COUNSEL | -913 | $139.29 | -$127.18K | SELL | -2.04% | 43.939K | Mar 01 - Mar 02 | View |
| Feb 27, 2023 | Michael E Prevoznik | SVP & GENERAL COUNSEL | 216 | $143.77 | -$320.02K | GRANT | 0.48% | 44.851K | Feb 23 - Feb 24 | View |
| Feb 27, 2023 | Catherine T Doherty | SVP, REGIONAL BUSINESSES | 1.186K | $143.76 | -$381.24K | GRANT | 1.65% | 73.166K | Feb 23 - Feb 24 | View |
| Dec 05, 2022 | Timothy M Ring | DIRECTOR | 0 | $104.94 | -$192.60K | SELL-OPTIONS | 0.00% | 24.149K | Dec 01 | View |
| Nov 29, 2022 | Catherine T Doherty | SVP, REGIONAL BUSINESSES | 0 | $117.90 | -$2.55M | SELL-OPTIONS | 0.00% | 71.959K | Nov 28 | View |
| Nov 02, 2022 | Timothy M Ring | DIRECTOR | 0 | $102.56 | -$165.98K | SELL-OPTIONS | 0.00% | 24.149K | Nov 01 | View |
| Oct 27, 2022 | Michael J Deppe | VP, CORP. CONTROLLER & CAO | 0 | $99.40 | -$1.41M | SELL-OPTIONS | 0.00% | 32.675K | Oct 26 | View |
| Oct 04, 2022 | Timothy M Ring | DIRECTOR | 0 | $92.31 | -$124.33K | SELL-OPTIONS | 0.00% | 23.933K | Oct 03 | View |
| Sep 06, 2022 | Timothy M Ring | DIRECTOR | 0 | $93.12 | -$127.59K | SELL-OPTIONS | 0.00% | 23.933K | Sep 01 | View |
| Aug 02, 2022 | Timothy M Ring | DIRECTOR | 0 | $98.45 | -$150.37K | SELL-OPTIONS | 0.00% | 23.933K | Aug 01 | View |
| Jul 05, 2022 | Timothy M Ring | DIRECTOR | 0 | $95.46 | -$152.03K | SELL-OPTIONS | 0.00% | 23.933K | Jul 01 | View |
| May 26, 2022 | Stephen H Rusckowski | CHAIRMAN, CEO AND PRESIDENT | 0 | $117.18 | -$1.18M | SELL-OPTIONS | 0.00% | 334.833K | May 25 | View |
| May 25, 2022 | Stephen H Rusckowski | CHAIRMAN, CEO AND PRESIDENT | 0 | $117.17 | -$16.53M | SELL-OPTIONS | 0.00% | 334.833K | May 23 - May 24 | View |
| May 19, 2022 | Michael E Prevoznik | SVP & GENERAL COUNSEL | 0 | $103.24 | -$3.72M | SELL-OPTIONS | 0.00% | 44.558K | May 17 | View |
| Mar 09, 2022 | Michael E Prevoznik | SVP & GENERAL COUNSEL | 0 | $131.47 | -$31.89K | GRANT | 0.00% | 44.53K | Mar 07 - Mar 08 | View |
| Mar 09, 2022 | Catherine T Doherty | SVP, GROUP EXEC. CLIN. FRAN. | 0 | $131.43 | -$36.00K | GRANT | 0.00% | 71.897K | Mar 07 - Mar 08 | View |
| Mar 02, 2022 | Michael E Prevoznik | SVP & GENERAL COUNSEL | -661 | $130.00 | -$85.93K | SELL | -1.46% | 44.531K | Feb 28 | View |
| Feb 28, 2022 | Catherine T Doherty | SVP, GROUP EXEC. CLIN. FRAN. | 578 | $126.26 | -$347.21K | GRANT | 0.81% | 71.899K | Feb 24 | View |
| Feb 28, 2022 | Michael E Prevoznik | SVP & GENERAL COUNSEL | 1.072K | $126.26 | -$210.73K | GRANT | 2.43% | 45.192K | Feb 24 | View |
| Dec 01, 2021 | Catherine T Doherty | SVP, GROUP EXEC. CLIN. FRAN. | 0 | $126.30 | -$2.29M | SELL-OPTIONS | 0.00% | 72.865K | Nov 29 | View |
| Jul 30, 2021 | Stephen H Rusckowski | CHAIRMAN, CEO AND PRESIDENT | 0 | $117.99 | -$6.63M | SELL-OPTIONS | 0.00% | 284.427K | Jul 28 - Jul 29 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.